老年营养风险指数对冠状动脉慢性完全闭塞病变患者经皮冠状动脉介入治疗术后远期预后的预测价值Predictive value of nutritional risk index in elderly patients with chronic total coronary artery occlusion after percutaneous coronary intervention
尹文峰,李倩,任洋,吴岳
摘要(Abstract):
目的 探讨经皮冠状动脉介入治疗(PCI)老年慢性完全闭塞(CTO)病变患者的营养状态与远期预后的关系。方法 纳入2013年6月至2017年10月于西安交通大学第一附属医院346例行PCI的老年CTO病变患者,根据老年营养风险指数(GNRI)分为3组:无营养不良风险组(GNRI≥98,186例),营养不良低风险组(92≤GNRI<98,114例),营养不良中度/高度风险组(GNRI<92,46例)。主要终点事件为全因死亡,次要终点事件为心血管死亡。结果 纳入的346例患者平均年龄为72岁,中位随访33个月,Kaplan-Meier生存分析显示,营养不良中/重度风险患者在全因死亡及心血管死亡方面的预后均比其他两组差(Log-rank检验,全因死亡:P=0.004,心血管死亡:P=0.003)。多因素Cox回归分析提示全因死亡与中/重度营养不良、淋巴细胞计数及左心室射血分数相关,心血管死亡只与中/重度营养不良相关。与无营养不良风险患者相比,营养不良中/重度风险患者全因死亡及心血管死亡风险显著增加(HR 2.580,95%CI 1.139~5.842,P=0.023;HR4.709,95%CI1.321~16.787,P=0.017)。结论 入院时GNRI是老年CTO病变患者PCI术后全因死亡及心血管死亡风险的独立预测指标。
关键词(KeyWords): 老年营养风险指数;冠状动脉慢性完全闭塞;经皮冠状动脉介入治疗;全因死亡;心血管死亡
基金项目(Foundation): 国家自然科学基金项目(81800205)
作者(Author): 尹文峰,李倩,任洋,吴岳
参考文献(References):
- [1] Stone GW, Kandzari DE, Mehran R, et al.Percutaneous recanalization of chronically occluded coronary arteries:a consensus document:part I[J]. Circulation, 2005, 112(15):2364-2372.
- [2] Elias J, van Dongen IM, Ramunddal T, et al.Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction[J]. Heart, 2018, 104(17):1432-1438.
- [3] Tajti P, Brilakis ES.Chronic total occlusion percutaneous coronary intervention:evidence and controversies[J]. J Am Heart Assoc, 2018, 7(2):e006732.
- [4] Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions[J]. Eur Heart J, 2018, 39(26):2484-2493.
- [5]田晋帆,雍婧雯,杨雪瑶,等.经皮冠状动脉介入/优化药物治疗对慢性完全闭塞病变患者长期死亡率影响的Meta分析[J].心肺血管病杂志,2021, 40(5):491-498.
- [6] Guan C, Yang W, Song L, et al. Association of acute procedural results with long-term outcomes after CTO PCI[J].JACC Cardiovasc Interv, 2021, 14(3):278-288.
- [7] Nakagomi A, Kohashi K, Morisawa T, et al.Nutritional status is associated with inflammation and predicts a poor outcome in patients with chronic heart failure[J]. J Atheroscler Thromb,2016, 23(6):713-727.
- [8] Wada H, Dohi T, Miyauchi K, et al.Prognostic impact of the geriatric nutritional risk index on long-term outcomes in patients who underwent percutaneous coronary intervention[J]. Am J Cardiol, 2017, 119(11):1740-1745.
- [9] Kunimura A, Ishii H, Uetani T, et al.Impact of geriatric nutritional risk index on cardiovascular outcomes in patients with stable coronary artery disease[J]. J Cardiol, 2017, 69(1):383-388.
- [10] Bouillanne O, Morineau G, Dupont C, et al.Geriatric nutritional risk index:a new index for evaluating at-risk elderly medical patients[J]. Am J Clin Nutr, 2005, 82(4):777-783.
- [11] Matsukuma Y, Tanaka S, Taniguchi M, et al.Association of geriatric nutritional risk index with infection-related mortality in patients undergoing hemodialysis:the Q-Cohort study[J].Clin Nutr, 2019, 38(1):279-287.
- [12] Sehgal IS, Dhooria S, Agarwal R, et al.Chronic obstructive pulmonary disease and malnutrition in developing countries[J].Curr Opin Pulm Med, 2017, 23(2):139-148.
- [13] Sze S, Pellicori P, Kazmi S, et al.Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure:a comparison with body mass index[J]. JACC Heart Fail, 2018, 6(6):476-486.
- [14] Clark AL, Sze S. Impact of malnutrition using geriatric nutritional risk index in heart failure with preserved ejection fraction[J].JACC Heart Fail, 2019, 7(8):676-677.
- [15] Matsuo Y, Kumakura H, Kanai H, et al.The geriatric nutritional risk index predicts long-term survival and cardiovascular or limb events in peripheral arterial disease[J]. J Atheroscler Thromb, 2020, 27(2):134-143.
- [16] Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan[J]. Endocr Pract, 2011, 17 Suppl 2:1-53.
- [17] Basta G, Chatzianagnostou K, Paradossi U, et al. The prognostic impact of objective nutritional indices in elderly patients with ST-elevation myocardial infarction undergoing primary coronary intervention[J]. Int J Cardiol, 2016, 221:987-992.
- [18]饶利,吴海燕,王红,等.预后营养指数对ST段抬高型心肌梗死患者疾病严重程度的早期评估价值的初步研究[J].四川大学学报(医学版),2019, 50(1):102-105.
- [19] Wada H, Dohi T, Miyauchi K, et al. Combined effect of nutritional status on long-term outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention[J].Heart Vessels, 2018, 33(12):1445-1452.
- [20] Don BR, Kaysen G.Serum albumin:relationship t o inflammation and nutrition[J]. Semin Dial, 2004, 17(6):432-437.
- [21] Liu M, Chan CP, Yan BP, et al. Albumin levels predict survival in patients with heart failure and preserved ejection fraction[J]. Eur J Heart Fail, 2012, 14(1):39-44.
- [22] Alam NN, Wright AK, Rutter MK, et al. Body mass index and cancer mortality in patients with incident type 2 diabetes:a population-based study of adults in England[J]. Diabetes Obes Metab,2022,24(4):620-630.
- [23] Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics[J].J Cell Physiol, 2019, 234(10):16812-16823.
- [24] Henriques JP, Hoebers LP, Ramunddal T, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI:the EXPLORE trial[J]. J Am Coll Cardiol,2016, 68(15):1622-1632.
- [25] Lee SW, Lee PH, Ahn JM, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion[J]. Circulation, 2019, 139(14):1674-1683.
- [26] Schols AM, Creutzberg EC, Buurman WA, et al. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1999, 160(4):1220-1226.
- [27] Kaysen GA. Malnutrition and the acute-phase reaction in dialysis patients-how to measure and how to distinguish[J]. Nephrol Dial Transplant, 2000, 15(10):1521-1524.
- [28] Flores EA, Bistrian BR, Pomposelli JJ, et al. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic ef fect with interleukin 1[J]. J Clin Invest,1989, 83(5):1614-1622.